+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gabapentin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Gabapentin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Gabapentin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 99 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5816497
Description Jump to:
Gabapentin, used for epilepsy, neuropathic pain, restless legs syndrome (RLS), and other conditions, addresses rising cases of diabetic neuropathy (30-50% of 422 million diabetes patients) and postherpetic neuralgia (0.3-1% annual incidence). The market is driven by an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050), with RLS prevalence reaching 10-20% in the elderly. Generic availability since 2004 has reduced costs by 70%, with prices as low as USD 1.35 daily, boosting accessibility. Gabapentin’s role in 20% of epilepsy cases and as a first-line treatment for chronic pain fuels demand. The global gabapentin market is estimated at USD 1.2-2.0 billion in 2025, with a CAGR of 3.3%-8.1% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high neuropathy prevalence and generic adoption, while Canada emphasizes chronic pain management.
  • Europe: Germany, France, and the UK drive growth with robust neurology care.
  • Asia Pacific: India and China see rising demand due to diabetes, with Japan focusing on elderly care.
  • Rest of the World: Brazil expands pain relief access, while the Middle East addresses neurological disorders.

Application Analysis

  • Epilepsy: Expected growth of 3.5%-8.3%, driven by 50 million patients. Trends focus on adjunctive therapy.
  • Neuropathic Pain: Projected growth of 3.8%-8.5%, linked to diabetic neuropathy. Advances emphasize first-line treatment.
  • Restless Legs Syndrome: Anticipated growth of 3.3%-8.1%, for elderly patients. Trends highlight symptom relief.
  • Others: Expected growth of 3.0%-7.8%, covering off-label uses. Developments prioritize versatile applications.

Type Analysis

  • Tablet: Expected growth of 3.5%-8.3%, favored for convenience. Trends focus on extended-release formulations.
  • Capsule: Projected growth of 3.3%-8.1%, for flexible dosing. Advances emphasize patient compliance.
  • Oral Solution: Anticipated growth of 3.0%-7.8%, for pediatric and elderly use. Trends highlight liquid formulations.

Key Market Players

  • Pfizer: Offers branded and generic gabapentin formulations.
  • Teva Pharmaceutical: Supplies affordable gabapentin generics.
  • Sun Pharmaceutical: Provides gabapentin for neurological conditions.
  • Aurobindo Pharma: Focuses on generic gabapentin production.
  • Viatris: Develops gabapentin for pain management.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low, due to widespread generics and low margins.
  • Threat of Substitutes: Moderate, with other pain medications competing, but gabapentin’s efficacy is established.
  • Bargaining Power of Buyers: High, as generic availability drives price competition.
  • Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
  • Competitive Rivalry: High, with companies competing on cost and formulation improvements.

Market Opportunities and Challenges

Opportunities:

  • Addressing 422 million diabetes patients with neuropathy.
  • Targeting 50 million epilepsy patients globally.
  • Leveraging an aging population, with 10-20% RLS prevalence.
  • Utilizing generics, reducing costs by 70%.
  • Supporting chronic pain, with 30-40% relief rates.
  • Expanding off-label uses for gabapentin.

Challenges:

  • Price erosion due to generic competition.
  • Potential side effects requiring monitoring.
  • Competition from alternative pain therapies.
  • Regulatory scrutiny on off-label prescribing.
  • Limited access in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Gabapentin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Gabapentin Market in North America (2020-2030)
8.1 Gabapentin Market Size
8.2 Gabapentin Market by End Use
8.3 Competition by Players/Suppliers
8.4 Gabapentin Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Gabapentin Market in South America (2020-2030)
9.1 Gabapentin Market Size
9.2 Gabapentin Market by End Use
9.3 Competition by Players/Suppliers
9.4 Gabapentin Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Gabapentin Market in Asia & Pacific (2020-2030)
10.1 Gabapentin Market Size
10.2 Gabapentin Market by End Use
10.3 Competition by Players/Suppliers
10.4 Gabapentin Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Gabapentin Market in Europe (2020-2030)
11.1 Gabapentin Market Size
11.2 Gabapentin Market by End Use
11.3 Competition by Players/Suppliers
11.4 Gabapentin Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Gabapentin Market in MEA (2020-2030)
12.1 Gabapentin Market Size
12.2 Gabapentin Market by End Use
12.3 Competition by Players/Suppliers
12.4 Gabapentin Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Gabapentin Market (2020-2025)
13.1 Gabapentin Market Size
13.2 Gabapentin Market by End Use
13.3 Competition by Players/Suppliers
13.4 Gabapentin Market Size by Type
Chapter 14 Global Gabapentin Market Forecast (2025-2030)
14.1 Gabapentin Market Size Forecast
14.2 Gabapentin Application Forecast
14.3 Competition by Players/Suppliers
14.4 Gabapentin Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Gabapentin Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.2 Teva Pharmaceutical
15.2.1 Company Profile
15.2.2 Main Business and Gabapentin Information
15.2.3 SWOT Analysis of Teva Pharmaceutical
15.2.4 Teva Pharmaceutical Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sun Pharmaceutical
15.3.1 Company Profile
15.3.2 Main Business and Gabapentin Information
15.3.3 SWOT Analysis of Sun Pharmaceutical
15.3.4 Sun Pharmaceutical Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.4 Aurobindo Pharma
15.4.1 Company Profile
15.4.2 Main Business and Gabapentin Information
15.4.3 SWOT Analysis of Aurobindo Pharma
15.4.4 Aurobindo Pharma Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.5 Azurity Pharmaceuticals
15.5.1 Company Profile
15.5.2 Main Business and Gabapentin Information
15.5.3 SWOT Analysis of Azurity Pharmaceuticals
15.5.4 Azurity Pharmaceuticals Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.6 Viatris
15.6.1 Company Profile
15.6.2 Main Business and Gabapentin Information
15.6.3 SWOT Analysis of Viatris
15.6.4 Viatris Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.7 Glenmark Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Gabapentin Information
15.7.3 SWOT Analysis of Glenmark Pharmaceuticals
15.7.4 Glenmark Pharmaceuticals Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.8 Zydus Pharmaceuticals
15.8.1 Company Profile
15.8.2 Main Business and Gabapentin Information
15.8.3 SWOT Analysis of Zydus Pharmaceuticals
15.8.4 Zydus Pharmaceuticals Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.9 Ascend Laboratories
15.9.1 Company Profile
15.9.2 Main Business and Gabapentin Information
15.9.3 SWOT Analysis of Ascend Laboratories
15.9.4 Ascend Laboratories Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.10 Apotex
15.10.1 Company Profile
15.10.2 Main Business and Gabapentin Information
15.10.3 SWOT Analysis of Apotex
15.10.4 Apotex Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.11 Amneal Pharmaceuticals
15.11.1 Company Profile
15.11.2 Main Business and Gabapentin Information
15.11.3 SWOT Analysis of Amneal Pharmaceuticals
15.11.4 Amneal Pharmaceuticals Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.12 Alvogen
15.12.1 Company Profile
15.12.2 Main Business and Gabapentin Information
15.12.3 SWOT Analysis of Alvogen
15.12.4 Alvogen Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
15.13 Cipla
15.13.1 Company Profile
15.13.2 Main Business and Gabapentin Information
15.13.3 SWOT Analysis of Cipla
15.13.4 Cipla Gabapentin Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Gabapentin Report
Table Data Sources of Gabapentin Report
Table Major Assumptions of Gabapentin Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Gabapentin Picture
Table Gabapentin Classification
Table Gabapentin Applications
Table Drivers of Gabapentin Market
Table Restraints of Gabapentin Market
Table Opportunities of Gabapentin Market
Table Threats of Gabapentin Market
Table COVID-19 Impact For Gabapentin Market
Table Raw Materials Suppliers
Table Different Production Methods of Gabapentin
Table Cost Structure Analysis of Gabapentin
Table Key End Users
Table Latest News of Gabapentin Market
Table Merger and Acquisition
Table Planned/Future Project of Gabapentin Market
Table Policy of Gabapentin Market
Table 2020-2030 North America Gabapentin Market Size
Figure 2020-2030 North America Gabapentin Market Size and CAGR
Table 2020-2030 North America Gabapentin Market Size by Application
Table 2020-2025 North America Gabapentin Key Players Revenue
Table 2020-2025 North America Gabapentin Key Players Market Share
Table 2020-2030 North America Gabapentin Market Size by Type
Table 2020-2030 United States Gabapentin Market Size
Table 2020-2030 Canada Gabapentin Market Size
Table 2020-2030 Mexico Gabapentin Market Size
Table 2020-2030 South America Gabapentin Market Size
Figure 2020-2030 South America Gabapentin Market Size and CAGR
Table 2020-2030 South America Gabapentin Market Size by Application
Table 2020-2025 South America Gabapentin Key Players Revenue
Table 2020-2025 South America Gabapentin Key Players Market Share
Table 2020-2030 South America Gabapentin Market Size by Type
Table 2020-2030 Brazil Gabapentin Market Size
Table 2020-2030 Argentina Gabapentin Market Size
Table 2020-2030 Chile Gabapentin Market Size
Table 2020-2030 Peru Gabapentin Market Size
Table 2020-2030 Asia & Pacific Gabapentin Market Size
Figure 2020-2030 Asia & Pacific Gabapentin Market Size and CAGR
Table 2020-2030 Asia & Pacific Gabapentin Market Size by Application
Table 2020-2025 Asia & Pacific Gabapentin Key Players Revenue
Table 2020-2025 Asia & Pacific Gabapentin Key Players Market Share
Table 2020-2030 Asia & Pacific Gabapentin Market Size by Type
Table 2020-2030 China Gabapentin Market Size
Table 2020-2030 India Gabapentin Market Size
Table 2020-2030 Japan Gabapentin Market Size
Table 2020-2030 South Korea Gabapentin Market Size
Table 2020-2030 Southeast Asia Gabapentin Market Size
Table 2020-2030 Australia Gabapentin Market Size
Table 2020-2030 Europe Gabapentin Market Size
Figure 2020-2030 Europe Gabapentin Market Size and CAGR
Table 2020-2030 Europe Gabapentin Market Size by Application
Table 2020-2025 Europe Gabapentin Key Players Revenue
Table 2020-2025 Europe Gabapentin Key Players Market Share
Table 2020-2030 Europe Gabapentin Market Size by Type
Table 2020-2030 Germany Gabapentin Market Size
Table 2020-2030 France Gabapentin Market Size
Table 2020-2030 United Kingdom Gabapentin Market Size
Table 2020-2030 Italy Gabapentin Market Size
Table 2020-2030 Spain Gabapentin Market Size
Table 2020-2030 Belgium Gabapentin Market Size
Table 2020-2030 Netherlands Gabapentin Market Size
Table 2020-2030 Austria Gabapentin Market Size
Table 2020-2030 Poland Gabapentin Market Size
Table 2020-2030 Russia Gabapentin Market Size
Table 2020-2030 MEA Gabapentin Market Size
Figure 2020-2030 MEA Gabapentin Market Size and CAGR
Table 2020-2030 MEA Gabapentin Market Size by Application
Table 2020-2025 MEA Gabapentin Key Players Revenue
Table 2020-2025 MEA Gabapentin Key Players Market Share
Table 2020-2030 MEA Gabapentin Market Size by Type
Table 2020-2030 Egypt Gabapentin Market Size
Table 2020-2030 Israel Gabapentin Market Size
Table 2020-2030 South Africa Gabapentin Market Size
Table 2020-2030 Gulf Cooperation Council Countries Gabapentin Market Size
Table 2020-2030 Turkey Gabapentin Market Size
Table 2020-2025 Global Gabapentin Market Size by Region
Table 2020-2025 Global Gabapentin Market Size Share by Region
Table 2020-2025 Global Gabapentin Market Size by Application
Table 2020-2025 Global Gabapentin Market Share by Application
Table 2020-2025 Global Gabapentin Key Vendors Revenue
Figure 2020-2025 Global Gabapentin Market Size and Growth Rate
Table 2020-2025 Global Gabapentin Key Vendors Market Share
Table 2020-2025 Global Gabapentin Market Size by Type
Table 2020-2025 Global Gabapentin Market Share by Type
Table 2025-2030 Global Gabapentin Market Size by Region
Table 2025-2030 Global Gabapentin Market Size Share by Region
Table 2025-2030 Global Gabapentin Market Size by Application
Table 2025-2030 Global Gabapentin Market Share by Application
Table 2025-2030 Global Gabapentin Key Vendors Revenue
Figure 2025-2030 Global Gabapentin Market Size and Growth Rate
Table 2025-2030 Global Gabapentin Key Vendors Market Share
Table 2025-2030 Global Gabapentin Market Size by Type
Table 2025-2030 Gabapentin Global Market Share by Type

Companies Mentioned

  • Pfizer
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Azurity Pharmaceuticals
  • Viatris
  • Glenmark Pharmaceuticals
  • Zydus Pharmaceuticals
  • Ascend Laboratories
  • Apotex
  • Amneal Pharmaceuticals
  • Alvogen
  • Cipla

Related Topics

Related Reports

Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form, By Type, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form, By Type, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Gabapentin Market by Route of Administration, Formulation, Dosage Form, Distribution Channel, End User, Indication - Global Forecast to 2030 - Product Image

Gabapentin Market by Route of Administration, Formulation, Dosage Form, Distribution Channel, End User, Indication - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Gabapentin - Global Strategic Business Report - Product Image

Gabapentin - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Gabapentin Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Gabapentin Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Gabapentin (CAS 60142-96-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Gabapentin (CAS 60142-96-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.